Hypopharyngeal
Showing 1 - 25 of 252
Larynx Cancer, Hypopharyngeal Cancer Trial in Shanghai (procedure, radiation, drug)
Recruiting
- Larynx Cancer
- Hypopharyngeal Cancer
- Surgery
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 9, 2023
Locally Advanced Hypopharyngeal Carcinoma Trial in Shanghai (drug, procedure, radiation)
Not yet recruiting
- Locally Advanced Hypopharyngeal Carcinoma
- three cycles (toripalimab + cetuximab + platinum)
- +2 more
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Nov 22, 2023
Hypopharyngeal Cancer Trial (Cisplatin/Nedaplatin, albumin paclitaxel)
Not yet recruiting
- Hypopharyngeal Cancer
- Cisplatin/Nedaplatin, albumin paclitaxel
- (no location specified)
May 5, 2023
The Voice asTool to Detect Recurrence of Laryngeal and
Not yet recruiting
- Laryngeal Cancer
- Hypopharyngeal Cancer
- Voice recording, ENT (Ear, Nose and Throat) examination including transnasal fiberendoscopy, and VHI-30-questionnaire
-
Bern, SwitzerlandDepartment of Oto-Rhino-Laryngology, Head and Neck Surgery, Inse
May 30, 2023
to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally
Recruiting
- to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
- Capecitabine 500Mg Oral Tablet
-
Shanghai, ChinaEye & ENT Hospital, Fudan University
Jul 2, 2023
Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx Trial in Rotterdam (CRGD-ZW800-1)
Not yet recruiting
- Squamous Cell Carcinoma of the Larynx
- Squamous Cell Carcinoma of the Hypopharynx
-
Rotterdam, Zuid-Holland, NetherlandsErasmus Medical Center
Feb 21, 2023
Laryngeal Cancer, Hypopharyngeal Cancer Trial in Shanghai (Toripalimab)
Recruiting
- Laryngeal Cancer
- Hypopharyngeal Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 12, 2022
Sore Throat Trial (Hypopharyngeal packing, Without Hypopharyngeal packing)
Withdrawn
- Sore Throat
- Hypopharyngeal packing
- Without Hypopharyngeal packing
- (no location specified)
Aug 29, 2022
Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication
Completed
- Caregiver
- +37 more
- Communication Intervention
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 14, 2022
Hypopharyngeal Carcinoma Trial in China (drug, radiation, procedure)
Not yet recruiting
- Hypopharyngeal Carcinoma
- Docetaxel
- +4 more
-
Beijing, Beijing, China
- +3 more
Aug 9, 2022
Immune Biomarker Study for Head and Neck Cancer
Recruiting
- Head and Neck Cancer
- +4 more
- Sampling
-
Erlangen, Bavaria, Germany
- +2 more
Jan 23, 2023
Blood Tests and Questionnaires in Studying Adherence to
Recruiting
- Carcinoma of Unknown Primary
- +30 more
- Biospecimen Collection
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Dec 12, 2022
Programmed Death Ligand-1 in Nasopharyngeal and Hyypopharyngeal
Not yet recruiting
- Nasopharyngeal and Hypopharyngeal Carcinoma
- immunohistochemical
-
Sohag, EgyptSohag University Hospital
Oct 23, 2022
Hypopharyngeal Carcinoma, Immunotherapy, Chemo Trial in Shanghai (Docetaxel, Cisplatin, Capecitabine)
Recruiting
- Hypopharyngeal Carcinoma
- +2 more
- Docetaxel
- +3 more
-
Shanghai, Shanghai, ChinaEye & ENT Hospital, Fudan University
Dec 1, 2021
Hypopharyngeal Cancer, Immunotherapy, Induction Chemo Trial in Guangzhou (Camrelizumab)
Recruiting
- Hypopharyngeal Cancer
- +2 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Aug 14, 2021
Laryngeal Cancer, Hypopharynx Cancer, Laryngeal Tumors Trial in Shanghai (chemo TP regimen combined with Toripalimab)
Recruiting
- Laryngeal Cancer
- +2 more
- chemotherapy TP regimen combined with Toripalimab
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 2, 2022
Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +23 more
- Biospecimen Collection
- +2 more
-
Los Angeles, California
- +1 more
Jul 7, 2022
Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- +11 more
- KEYTRUDA®
- (no location specified)
Nov 17, 2023
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +24 more
- Carboplatin
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 18, 2022
Hypopharyngeal Pressure Changes Between Before and After Swallowing Rehabiliation Trial (the early swallowing rehabilitation
Not yet recruiting
- Hypopharyngeal Pressure Changes Between Before and After Swallowing Rehabiliation
- the early swallowing rehabilitation program
- (no location specified)
Aug 10, 2022
Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV
Recruiting
- Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +28 more
- Cisplatin
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 16, 2022
Hypopharyngeal Mean Pressure Trial (supraglottic airway device, endotracheal intubation)
Not yet recruiting
- Hypopharyngeal Mean Pressure
- supraglottic airway device
- endotracheal intubation
- (no location specified)
Jun 12, 2022
Laryngeal Disease, Laryngeal Lesions, Hypopharyngeal Lesions Trial in Ostrava, Hradec Králové (Enhanced contact endoscopy,
Recruiting
- Laryngeal Disease
- +6 more
- Enhanced contact endoscopy
- +2 more
-
Ostrava, Moravian-Silesian Region, Czechia
- +1 more
Jun 29, 2021
Locoregionally Advanced Laryngo-hypopharyngeal Squamous Cell Cancer Trial in Shanghai (5-Fluorouracil, Cisplatin, Toripalimab)
Recruiting
- Locoregionally Advanced Laryngo-hypopharyngeal Squamous Cell Cancer
- 5-Fluorouracil, Cisplatin, Toripalimab
-
Shanghai, ChinaDepartment of Oncology, Ruijin Hospital
Jun 14, 2021